Farther Finance Advisors, LLC

Position in OCUL — Ocular Therapeutix, Inc

CIK 1992825 SAN FRANCISCO, CA

Position in OCUL

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$15,014

+$4,410 QoQ

Shares Held

1,529

+22.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#223

of 257 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,699,251 across 282 Biotechnology names. OCUL ranks #94 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,922	$2,444,905
2	MRNA	Moderna, Inc.	15,429	$1,080,492
3	ARWR	Arrowhead Pharmaceuticals, Inc.	12,088	$985,292
4	HALO	Halozyme Therapeutics, Inc.	11,241	$879,833
5	EXEL	Exelixis, Inc.	14,171	$771,044
6	REGN	Regeneron Pharmaceuticals, Inc.	1,075	$670,305
7	VKTX	Viking Therapeutics, Inc.	15,171	$591,820
8	BMRN	Biomarin Pharmaceutical Inc	7,871	$450,378

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,014	1,529	+22.1%	Shares	Sole	2026-07-17
2026-03-31	$10,604	1,252	+111.8%	Shares	Sole	2026-04-07
2025-12-31	$7,174	591	-37.5%	Shares	Sole	2026-01-23
2025-09-30	$11,058	946	+236.7%	Shares	Sole	2025-10-14
2025-06-30	$2,607	281	-71.0%	Shares	Sole	2025-07-11
2025-03-31	$7,110	970	+9600.0%	Shares	Sole	2025-04-14
2024-12-31	$85	10	0.0%	Shares	Sole	2025-02-10
2024-09-30	$87	10	0.0%	Shares	Sole	2024-10-29
2024-06-30	$68	10	0.0%	Shares	Sole	2024-07-31
2024-03-31	$91	10	—	Shares	Sole	2024-05-14
No filing history on record for this holder in this stock.